Neuroscience Market, By Component (Instrument, Software and Services), By End User (Hospital, Diagnostic Laboratories, Research Institutes, and Academic Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Neuroscience is the study of nervous system, which is related to evaluating and imaging of the brain activity. Neuroscience is a broad term thatfocuses on molecular, cellular, developmental, structural, functional, evolutionary, computing, psychosocial, and medical aspects of the nervous system. The advancement in biology, pharmaceutical science, medicine, cognitive science, biomedical engineering is evolving neuroscience. Neuroscience have application in variety of areas for better understanding of pathophysiology and symptoms various for chronic neurological disease such as epilepsy and Alzheimer disease. This aids in developing novel treatment for these diseases.
Various research activities such as investigating neural activity, disease modeling, safety and toxicity studies, and drug discovery are performed with the help of neuroscience instruments such as computed tomography scan, magnetic resonance imaging(MRI), microscopes, signal processing system, brain neuron interface system, other recording, and stimulation solutions.
Furthermore, rising number of neurological disorder cases is expected to drive the market growth over the forecast period. For instance, according to the World Health Organization, in September 2019, 50 million people had dementia, and around 10 million new cases are added every year.
Market Dynamics
Product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, in May 2022, the U.S. Food and Drug Administration approved marketing of the first in vitro diagnostics test for early detection of amyloid plaques associated with Alzheimer’s disease. When adult patients 55 years of age and older appear with cognitive impairment and are being assessed for Alzheimer's disease and other causes of cognitive decline, the Lumipulse G-Amyloid Ratio (1-42/1-40) test is used.
Key features of the study:
- This report provides in-depth analysis of the global neuroscience market and provides market size (US$ billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global neuroscience market based on the following parameters–company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Alpha Omega, Inc., GE Healthcare, Axion Biosystems, Inc., Siemens Healthineers, Scientifica Ltd., Blackrock Microsystems LLC, Femtonics Ltd., LaVision Biotec GmbH, Intan Technologies, NeuroNexus Technologies, Inc., Newport Corporation, Neuralynx Inc., Plexon Inc., Mediso Medical Imaging Systems, Noldus Information Technology, Sutter Instrument Corporation, Thomas Recording GmbH, Trifoil Imaging Inc, and other prominent key players
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- Global neuroscience market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroscience market
Detailed Segmentation:
- Global Neuroscience Market, Component
Instrument
Software
Services
- Global Neuroscience Market, By End User
Hospitals
Diagnostic Laboratories
Research Institutes
Academic Institutes
- Global NeuroscienceMarket, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Alpha Omega, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
GE Healthcare
Axion Biosystems, Inc.
Siemens Healthineers
Scientifica Ltd.
Blackrock Microsystems LLC
Femtonics Ltd.,
LaVision Biotec GmbH
Intan Technologies
NeuroNexus Technologies, Inc
Newport Corporation
Neuralynx Inc.
Plexon Inc.
Mediso Medical Imaging Systems
Noldus Information Technology
Sutter Instrument Corporation
Thomas Recording GmbH
Trifoil Imaging Inc
“*” marked represents similar segmentation in other categories in the respective section.